Contact

Early is Good’s founder, Dr. Thakshila Liyanage, will introduce BCDx, a breakthrough in bladder cancer diagnosis test, at the ACS on August 16

Dr. Thakshila Liyanage Introduces BCDx: A Breakthrough in Bladder Cancer Detection at ACS

Early is Good’s founder, Dr. Thakshila Liyanage, will introduce BCDx, a breakthrough in bladder cancer diagnosis, at the ACS on August 16. This non-invasive test, detecting 12 biomarkers, promises better patient comfort and a drastic cost reduction in healthcare.

Visit ACS session for details.

Latest From News

Press Release: Early is Good Receives NIH Phase 2 Grant to Develop Innovative Bladder Cancer Monitoring Test

Press Release: Early is Good Announces Collaboration with Mayo Clinic to Develop a Comprehensive Liquid Biopsy Test for Men with Advanced Prostate Cancer

Early is Good’s founder, Dr. Thakshila Liyanage, will introduce BCDx, a breakthrough in bladder cancer diagnosis test, at the ACS on August 16